P636-0417 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide

P636-0417 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide
P636-0417 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P636-0417
1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P636-0417

Molecular Formula

C25H32N6O2 (C25 H32 N6 O2)

Compound Name

1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[1-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide

IUPAC name

1-(1-benzyl-6-oxo-16-dihydropyridazin-4-yl)-N-[1-(135-trimethyl-1H-pyrazol-4-yl)ethyl]piperidine-4-carboxamide

SMILES

CC(c1c(C)n(C)nc1C)NC(C(CC1)CCN1C(C=NN1Cc2ccccc2)=CC1=O)=O

InChI

InChI=1S/C25H32N6O2/c1-17(24-18(2)28-29(4)19(24)3)27-25(33)21-10-12-30(13-11-21)22-14-23(32)31(26-15-22)16-20-8-6-5-7-9-20/h5-9,14-15,17,21H,10-13,16H2,1-4H3,(H,27,33)/t17-/m0/s1

InChI Key

XACLAZTVCXDIBW-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD27608538

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.401

Distribution Coefficient, logD

1.163

Water Solubility, LogSw

-2.11

Polar Surface Area

70.909

Acid Dissociation Constant (pKa)

13.04

Base Dissociation Constant (pKb)

5.79

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

P636-0417 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P636-0417 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P636-0417?
Check Price and Availability of P636-0417, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P636-0417 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P636-0417
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P636-0417
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P636-0417 available by request